Nigel J. Temperton

Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit.

The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination.

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus.

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays.

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis.

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin.

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients.

Pseudotyped Viruses for Influenza.